Catalyst Wire Dossier Catalyst Wire Dossier

AND017

· Kind Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for AND017, covering 2023-10-04 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) [Phase 3]

See pricing